The Skin Microbiome: A New Key Player in Melanoma, From Onset to Metastatic Stage
Pigment Cell & Melanoma Research · 2025
DOI: 10.1111/pcmr.13224 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pigment Cell & Melanoma Research, 2025. Verfasst von Jean-Matthieu L'Orphelin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Unicaen, Inserm U1086 Anticipe, Normandie Univ, Caen, France. Hauptthemen laut MEDLINE: Melanoma, Microbiota, Skin, Skin Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The skin microbiome plays a crucial role in maintaining skin health, defending the body against harmful pathogens, and interacting with melanoma. The composition of the skin microbiome can be affected by factors like age, gender, ethnicity, lifestyle, diet, and UV exposure. Certain bacteria like Staphylococcus and Veillonella are important for wound healing, while Cutibacterium acnes can play a role in dermatoses. UV radiation alters the skin microbiome, originates a “UV‐resistome” and can lead to skin cancer initiation. Specifically, Staphylococcus epidermidis has shown protective effects against skin cancer, whereas Cutibacterium acnes can induce apoptosis in melanocytes postirradiation. The microbiome also interacts with melanoma treatment, affecting responses to immune checkpoint inhibitors. Strategies like bacteriotherapy, involving the manipulation of the gut microbiome but also the skin microbiome (with the gut–skin axis or through topical treatment) could improve treatment outcomes and show promise in melanoma therapy. Understanding the complex interplay between the skin microbiome, UV exposure, and melanoma development is crucial for developing personalized therapeutic approaches. Investigation into the skin microbiome and its potential role in melanoma progression continues to be an exciting area of research with implications for future therapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unicaen, Inserm U1086 Anticipe, Normandie Univ, Caen, France.
- Department of Dermatology, Caen-Normandy University Hospital, Caen, France.
- Inserm, Cnrs, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, Nantes Université, Nantes, France.
ORCID-Profile: Jean-Matthieu L'Orphelin
Zitieren
APA
L'Orphelin, J. M., Dompmartin, A., & Dréno, B. (2025). The Skin Microbiome: A New Key Player in Melanoma, From Onset to Metastatic Stage. Pigment Cell & Melanoma Research. https://doi.org/10.1111/pcmr.13224
Vancouver
L'Orphelin JM, Dompmartin A, Dréno B. The Skin Microbiome: A New Key Player in Melanoma, From Onset to Metastatic Stage. Pigment Cell & Melanoma Research. 2025. doi:10.1111/pcmr.13224
BibTeX
@article{LOrphelin2025,
author = {L'Orphelin, Jean-Matthieu and Dompmartin, Anne and Dréno, Brigitte},
title = {The Skin Microbiome: A New Key Player in Melanoma, From Onset to Metastatic Stage},
journal = {Pigment Cell & Melanoma Research},
year = {2025},
doi = {10.1111/pcmr.13224}
}
EUVIMED